Sinopharm Group Co., Ltd. Stock Other OTC
Equities
SHTDY
US82937K1016
Pharmaceuticals
Sales 2024 * | 649B 90.04B 123B | Sales 2025 * | 707B 98.08B 134B | Capitalization | 58.54B 8.12B 11.1B |
---|---|---|---|---|---|
Net income 2024 * | 9.61B 1.33B 1.82B | Net income 2025 * | 10.58B 1.47B 2.01B | EV / Sales 2024 * | 0.11 x |
Net Debt 2024 * | 11.49B 1.59B 2.18B | Net Debt 2025 * | 9.36B 1.3B 1.77B | EV / Sales 2025 * | 0.1 x |
P/E ratio 2024 * |
6.08
x | P/E ratio 2025 * |
5.53
x | Employees | - |
Yield 2024 * |
4.98% | Yield 2025 * |
5.47% | Free-Float | 42.99% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Liu
PSD | President | 55 | 09-01-08 |
Shuang Jun Xu
PRN | Corporate Officer/Principal | 55 | 11-02-28 |
Zhong Xi Cai
PRN | Corporate Officer/Principal | 59 | 10-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 52 | 10-04-30 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | 19-01-10 |
Dong Jiu Li
BRD | Director/Board Member | 59 | 13-10-17 |
1st Jan change | Capi. | |
---|---|---|
+15.05% | 69.5B | |
-1.82% | 24.09B | |
+8.13% | 8.2B | |
-20.55% | 7.97B | |
+19.12% | 4.32B | |
0.00% | 4.19B | |
-3.30% | 3.89B | |
+23.97% | 3.62B | |
+8.64% | 3.41B |